Lupin launches additional strength of generic Lotrel capsules

06 Jul 2011 Evaluate

Pharma major, Lupin’s subsidiary - Lupin Pharmaceuticals Inc (LPI) has been granted the final approval by the United Food & Drug Administration (USFDA) for the company’s abbreviated drug application (ANDA) for Amlodipine/ Benazepril 5mg/40mg and 10 mg/40 mg capsules. The commercial shipments of the products have commenced.

This approval completes the product line as the company was granted final approval for Amlodipine/Benazepril 2.5 mg/ 10 mg, 5mg/10mg, 5mg/20 mg and 10 mg/20 mg capsules in February 2010.

Lupin’s Amlodipine/ Benazepril capsules are the AB rated generic equivalents of the Novartis Lotrel capsules indicated for the treatment of hypertension. Amlodipine/ Benazepril 5mg/40mg and 10 mg/40 mg capsules had annual sales of approximately $290 million for the twelve months ended March 2011.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×